Publication Name	World Journal of Gastroenterology
Manuscript ID	32741
Country	China

Received	2017-01-22 09:07
Peer-Review Started	2017-01-22 09:10
To Make the First Decision	2017-02-21 09:31
Return for Revision	2017-02-21 16:47
Revised	2017-03-07 17:24
Second Decision	2017-03-17 18:08
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-03-21 11:18
Articles in Press	2017-03-21 11:18
Publication Fee Transferred	2017-04-14 23:10
Edit the Manuscript by Language Editor	2017-04-25 06:51
Typeset the Manuscript	2017-05-18 07:54
Publish the Manuscript Online	2017-05-27 00:33

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2017.Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Observational Study
Article Title	Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao and Xiu-Yan Wang
Funding Agency and Grant Number
Corresponding Author	Xiu-Yan Wang, Chief Physician, Department of Ultrasound, Tongji Hospital, Medical School of Tongji University, No 389 Xincun Road, Shanghai 200065, China. tjwangxiuyan@163.com
Key Words	MiR-106b; Hepatocellular carcinoma; ROC curve; Random sampling survey
Core Tip	Primary hepatocellular carcinoma (HCC) is the cause of a large number of patient deaths each year, and presents a heavy financial burden to the community and family. MicroRNAs (miRNAs) have been proven to be involved in the development of various cancers, as well as during the development process. Among these miRNAs, miR-106b has been shown to be a potential diagnostic marker for early HCC. We randomly selected the sera of medical examiners and detected their miR-106b level and further verified the diagnostic value of miR-106b, and provided more data to support the clinical application of miR-106b in evidence-based medicine.
Publish Date	2017-05-27 00:33
Citation	Shi BM, Lu W, Ji K, Wang YF, Xiao S, Wang XY. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2017; 23(20): 3713-3720
URL	http://www.wjgnet.com/1007-9327/full/v23/i20/3713.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i20.3713

Full Article (PDF)	WJG-23-3713.pdf
Full Article (Word)	WJG-23-3713.doc
Manuscript File	32741-Review.doc
Answering Reviewers	32741-Answering reviewers.pdf
Audio Core Tip	32741-Audio core tip.m4a
Biostatistics Review Certificate	32741-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	32741-Conflict-of-interest statement.pdf
Copyright License Agreement	32741-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	Informed_Consent_Statement_20170121174204.doc
Institutional Review Board Approval Form or Document	32741-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	32741-Language certificate.pdf
Peer-review Report	32741-Peer-review(s).pdf
Scientific Misconduct Check	32741-Scientific misconduct check.pdf
Scientific Editor Work List	32741-Scientific editor work list.pdf